Richter's Transformation after CD-19 Directed CAR-T Cells for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

被引：2
|
作者：
Blackmon, Amanda [1 ]
Danilov, Alexey V. [2 ]
Wang, Lili [3 ]
Pillai, Raju [4 ]
Mirshkarlo, Hormoz Babaei [5 ]
Rosen, Steven T. [6 ]
Siddiqi, Tanya [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[2] City Hope Comprehens Canc Ctr, Duarte, CA USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Syst Biol, Monrovia, CA USA
[4] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA
[5] City Hope Natl Med Ctr, Duarte, CA USA
[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149815
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1430
引用
收藏
页数：4
相关论文
共 50 条
  • [21] TRANSCEND CLL 004: Minimal Residual Disease Negative Responses After Lisocabtagene Maraleucel (JCAR017), a CD19-Directed CAR T-Cell Product, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    O'Brien, Susan M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (07) : 16 - 18
  • [22] A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma
    Zhang, Hua
    Gao, Lei
    Liu, Li
    Wang, Jishi
    Wang, Sanbin
    Gao, Li
    Zhang, Cheng
    Liu, Yao
    Kong, Peiyan
    Liu, Jia
    He, Jiaping
    Han, Yu
    Shi, Hua
    He, Yan
    Ye, Xun
    Zhao, Yi
    Cao, Wei
    Shen, Lianjun
    Zhang, Xi
    BLOOD, 2019, 134
  • [23] A retrospective single-center analysis of CD-19 directed CAR T-cell therapy in relapsed/refractory mantle cell lymphoma
    Banerjee, Titas
    Newman, Matthew
    Chen, Andy
    Maziarz, Richard T.
    Schachter, Levanto
    Spurgeon, Stephen E.
    Vallurupalli, Anusha
    LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1472 - 1475
  • [24] Potent anti-leukemia activities of humanized CD19-targeted CAR-T cells in patients with relapsed/refractory acute lymphoblastic leukemia
    Cao, J.
    Wang, G.
    Zheng, J.
    Xu, K.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1719 - 1720
  • [25] A Feasibility and Safety Study of a New CD19-Directed Fast CAR-T Therapy for Refractory and Relapsed B Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    He, Jiaping
    Zhang, Xian
    Wang, Zhenguang
    Zhang, Yongliang
    Cai, Songbai
    Sun, Zhe
    Ye, Xun
    He, Yan
    Shen, Lianjun
    He, Jiujiang
    Zhang, Gailing
    Song, Dan
    Zhang, Min
    Hu, Xiaona
    Li, Jingjing
    Xia, Shulian
    Xu, Li
    Cao, Wei
    Lu, Peihua
    BLOOD, 2019, 134
  • [26] CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS FOR RELAPSED, REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Melenhorst, J. Joseph
    Porter, David L.
    Lacey, Simon F.
    Loren, Alison W.
    Jemison, Christina
    Gilmore, Joan
    McConville, Holly
    Capobianchi, James
    Lledo, Lester
    Chew, Anne
    Zheng, Zhaohui
    Levine, Bruce L.
    June, Carl H.
    LEUKEMIA RESEARCH, 2014, 38 : S12 - S12
  • [27] The Great Imitator: Systemic Nocardiosis Mimicking Richter's Transformation in Relapsed Chronic Lymphocytic Leukemia
    Parikh, Sameer A.
    Bhusal, Yogesh
    Faderl, Stefan H.
    Wierda, William G.
    O'Brien, Susan
    Kantarjian, Hagop
    Adachi, Javier A.
    Burger, Jan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : E732 - E734
  • [28] A Phase 2 Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS)
    Crombie, Jennifer L.
    Ryan, Christine E.
    Ren, Yue
    Tyekucheva, Svitlana
    Carey, Celeste
    Zou, Aaron
    Normilus, Samantha
    Montegaard, Josie
    Soumerai, Jacob D.
    Bhandari, Shruti
    Arnason, Jon E.
    Alencar, Alvaro J.
    Kim, Austin I.
    Parry, Erin M.
    Armand, Philippe
    Fisher, David C.
    Brown, Jennifer R.
    Davids, Matthew S.
    BLOOD, 2024, 144 : 4628 - 4629
  • [29] Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL
    Geyer, Mark B.
    Riviere, Isabelle
    Senechal, Brigitte
    Wang, Xiuyan
    Wang, Yongzeng
    Purdon, Terence J.
    Hsu, Meier
    Devlin, Sean M.
    Palomba, M. Lia
    Halton, Elizabeth
    Bernal, Yvette
    van Leeuwen, Dayenne G.
    Sadelain, Michel
    Park, Jae H.
    Brentjens, Renier J.
    JCI INSIGHT, 2019, 4 (09)
  • [30] Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database
    Elnair, Radowan
    Ellithi, Moataz
    Kallam, Avyakta
    Shostrom, Valerie
    Bociek, Robert G.
    ANNALS OF HEMATOLOGY, 2021, 100 (10) : 2513 - 2519
12345